» Articles » PMID: 36366526

Global Transcriptome Analyses of Cellular and Viral MRNAs During HAdV-C5 Infection Highlight New Aspects of Viral MRNA Biogenesis and Cytoplasmic Viral MRNA Accumulations

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2022 Nov 11
PMID 36366526
Authors
Affiliations
Soon will be listed here.
Abstract

It is well established that human adenoviruses such as species C, types 2 and 5 (HAdV-C2 and HAdV-C5), induce a nearly complete shutoff of host-cell protein synthesis in the infected cell, simultaneously directing very efficient production of viral proteins. Such preferential expression of viral over cellular genes is thought to be controlled by selective nucleocytoplasmic export and translation of viral mRNA. While detailed knowledge of the regulatory mechanisms responsible for the translation of viral mRNA is available, the viral or cellular mechanisms of mRNA biogenesis are not completely understood. To identify parameters that control the differential export of viral and cellular mRNAs, we performed global transcriptome analyses (RNAseq) and monitored temporal nucleocytoplasmic partitioning of viral and cellular mRNAs during HAdV-C5 infection of A549 cells. Our analyses confirmed previously reported features of the viral mRNA expression program, as a clear shift in viral early to late mRNA accumulation was observed upon transition from the early to the late phase of viral replication. The progression into the late phase of infection, however, did not result in abrogation of cellular mRNA export; rather, viral late mRNAs outnumbered viral early and most cellular mRNAs by several orders of magnitude during the late phase, revealing that viral late mRNAs are not selectively exported but outcompete cellular mRNA biogenesis.

Citing Articles

Identification of Adenovirus E1B-55K Interaction Partners through a Common Binding Motif.

Chalabi Hagkarim N, Ip W, Bertzbach L, Abualfaraj T, Dobner T, Molloy D Viruses. 2023; 15(12).

PMID: 38140597 PMC: 10747525. DOI: 10.3390/v15122356.


Adenovirus E1B-55K controls SUMO-dependent degradation of antiviral cellular restriction factors.

Ip W, Tatham M, Krohne S, Gruhne J, Melling M, Meyer T J Virol. 2023; 97(11):e0079123.

PMID: 37916833 PMC: 10688335. DOI: 10.1128/jvi.00791-23.


The adenoviral E4orf3/4 is a regulatory polypeptide with cell transforming properties in vitro.

Ip W, Bertzbach L, Speiseder T, Dobner T Tumour Virus Res. 2023; 15:200254.

PMID: 36707050 PMC: 10258410. DOI: 10.1016/j.tvr.2023.200254.


Special Issue "New Frontiers in Small DNA Virus Research".

Strati K, Pyeon D Viruses. 2023; 15(1).

PMID: 36680299 PMC: 9865906. DOI: 10.3390/v15010259.

References
1.
Zhao H, Chen M, Pettersson U . A new look at adenovirus splicing. Virology. 2014; 456-457:329-41. DOI: 10.1016/j.virol.2014.04.006. View

2.
Ginsberg H, LUNDHOLM U, Linne T . Adenovirus DNA-binding protein in cells infected with wild-type 5 adenovirus and two DNA-minus, temperature-sensitive mutants, H5ts125 and H5ts149. J Virol. 1977; 23(1):142-51. PMC: 515810. DOI: 10.1128/JVI.23.1.142-151.1977. View

3.
Pollard A, Launay O, Lelievre J, Lacabaratz C, Grande S, Goldstein N . Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis. 2020; 21(4):493-506. DOI: 10.1016/S1473-3099(20)30476-X. View

4.
Crisostomo L, Soriano A, Mendez M, Graves D, Pelka P . Temporal dynamics of adenovirus 5 gene expression in normal human cells. PLoS One. 2019; 14(1):e0211192. PMC: 6345434. DOI: 10.1371/journal.pone.0211192. View

5.
Price A, Steinbock R, Lauman R, Charman M, Hayer K, Kumar N . Novel viral splicing events and open reading frames revealed by long-read direct RNA sequencing of adenovirus transcripts. PLoS Pathog. 2022; 18(9):e1010797. PMC: 9499273. DOI: 10.1371/journal.ppat.1010797. View